• Manufacturing

BIA guide to the SPC manufacturing waiver

On 1 July 2019, legislation came into effect that amends the EU Supplementary protection certificates (SPC) Regulation. This guide, prepared by the BIA’s IP Advisory Committee (IPAC), provides an overview for members concerning the changes.

Leading Innovation|The UK's ATMP Landscape

The Alliance for Regenerative Medicine (ARM) and the BioIndustry Association (BIA) have published a report setting out the scope of the UK’s robust and growing Advanced Therapy Medicinal Products (ATMPs) sector which includes the development of potentially transformative cell and gene therapies.

Influencing and shaping our sector | BIA update: April - July 2019

The BioIndustry Association (BIA)’s ongoing engagement enables our members’ voices to be heard at the highest levels. This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences sector, from April to July 2019.

UK life sciences: Catalysing investment and growth

This report sets out how the UK life sciences sector is driving investment and growth and makes the case for increased cost-effective public investment in the sector.